Navigation Links
ACMG 2013 Clinical Genetics Meeting -- Complimentary press registration is now open

Health, science and genetics reporters are invited to register now for the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, March 19-23, 2013 at the Phoenix Convention Center. From Genetic Testing to Whole Genome/Exome Sequencing, the focus of the ACMG Meeting is on the actual practice of genetics and genomics in healthcare today and in the future. The conference will showcase the latest breakthroughs in genetics research and its practical applications to medical practice and public health. The ACMG Annual Meeting attracts medical and scientific leaders from around the world who are working to apply research in genetics and the human genome to the diagnosis, management, treatment and prevention of genetic conditions and rare and common diseases.

From the cytogenomics of cancer to neurogenetics; from noninvasive prenatal diagnosis to whole genome analysis; and from medical reimbursement issues to next generation sequencing, reporters will hear about the latest research; have the opportunity to interact with doctors, laboratory professionals and genetic counselors about what is happening right now in genetics and genomics; and view the latest products available in the extensive exhibit hall.

Topics range from common conditions to rare diseases. Sessions include information of interest to the general public, to health professionals and to the industry/trade.

The ACMG Meeting is the genetics meeting most focused on the practical applications of genetic discoveries in a clinical setting.


Contact: Kathy Beal
American College of Medical Genetics

Page: 1

Related biology news :

1. Clinical Endocrinology of Companion Animals
2. 3 new research units, 1 new clinical research unit
3. New clinical trial explores use of smartphone application for postpartum weight loss
4. Clinical trial tests rice bran to prevent cancer
5. Greenphire CEO Sam Whitaker speaks on Sunshine Act and Clinical Trial Payments
6. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
7. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
8. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
9. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
10. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
11. BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
Post Your Comments:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
Breaking Biology Technology: